DOI:10.2214/AJR.05.0337
AJR 2006; 187:1192-1198
© American Roentgen Ray Society
Macrocystic Neoplasms of the Pancreas: CT Differentiation of Serous Oligocystic Adenoma from Mucinous Cystadenoma and Intraductal Papillary Mucinous Tumor
Sang Youn Kim1,
Jeong Min Lee1,
Se Hyung Kim1,
Kyung-Sook Shin1,2,
Young Jun Kim1,
Su Kyung An1,
Chang Jin Han1,
Joon Koo Han1 and
Byung Ihn Choi1
1 Department of Radiology and Institute of Radiation Medicine, Seoul National
University Hospital and College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul
110-744, Korea.
2 Present address: Department of Radiology, Chungnam National University
Hospital, Seoul, Korea.
Received February 27, 2005;
accepted after revision June 17, 2005.
Address correspondence to J. K. Han.
CME
This article is available for CME credit. See
www.arrs.org
for more information.
Abstract
OBJECTIVE. The purpose of our study was to determine useful CT
criteria for differentiating serous oligocystic adenomas of the pancreas from
other similarly presenting neoplasms, such as mucinous cystadenoma and
intraductal papillary mucinous tumor of the branch duct type.
MATERIALS AND METHODS. Forty-one patients with histologically
confirmed macrocystic neoplasms of the pancreas were enrolled: serous
oligocystic adenoma in 10 patients, mucinous cystadenoma in 13, and
intraductal papillary mucinous tumor in 18. Location, greatest dimension,
shape, presence of mural nodules, presence of wall calcification, and the
extent and degree of main pancreatic duct (MPD) dilatation were analyzed with
CT. The lesions were categorized into seven groups according to their shapes:
multicystic, lobulated contour with and without internal septation, smooth
contour with and without internal septation, pleomorphic cystic, and clubbed
fingerlike cystic. Comparative studies were performed using Fisher's exact
test and the Mann-Whitney U test.
RESULTS. Significant differences in lesion shape were found between
serous oligocystic adenoma and the other macrocystic neoplasms (mucinous
cystadenoma [p < 0.05], intraductal papillary mucinous tumor
[p < 0.05]). Serous oligocystic adenoma had a multicystic or
lobulated contour with or without septation, whereas mucinous cystadenoma had
a smooth contour with or without septation and intraductal papillary mucinous
tumor had either a pleomorphic or a clubbed fingerlike cystic shape. Serous
oligocystic adenoma showed proximal MPD dilatation from the lesion, whereas
intraductal papillary mucinous tumor showed distal or whole MPD dilatation
(p < 0.05). No significant difference was apparent among the three
diseases in terms of location, greatest dimension, or presence of
calcification or mural nodules.
CONCLUSION. Serous oligocystic adenoma of the pancreas has
characteristic CT findings that differentiate it from other cystic tumors. It
appears as a multicystic or lobulated cystic lesion with septation.
Keywords: abdominal imaging CT intraductal papillary mucinous tumor macrocystic serous adenoma mucinous cystadenoma pancreas pancreaticobiliary imaging serous oligocystic adenoma
Introduction
With the widespread use of abdominal CT, cystic neoplasms of the pancreas
are being increasingly recognized, but their accurate characterization and
differentiation remain difficult because of their overlapping morphologies.
Among them, the serous pancreatic cystadenoma is a common benign neoplasm. The
most common variety of serous cystadenoma is the serous microcystic adenoma.
The other, much less common variant of serous cystadenoma is serous
oligocystic adenoma, which has fewer but much larger cysts that are
histologically similar to those of serous microcystic adenoma
[1,
2]. Many authors have reported
that the incidence of serous oligocystic adenoma ranges from 10% to 25% of
serous pancreatic cystadenomas
[3-5].
Pathologists say that the macroscopic approach to diagnosis makes it easy
to differentiate serous oligocystic adenoma from serous microcystic adenoma
because the latter macroscopically tends to be a spongelike cystic lesion
lined by uniform glycogen-rich cuboidal epithelial cells. The question is
whether serous oligocystic adenomas have macroscopic findings similar to other
macrocystic tumors such as mucinous cystadenoma or intraductal papillary
mucinous tumor. Since the World Health Organization subclassified serous
macrocystic adenoma (a synonym for serous oligocystic adenoma) as a subgroup
of pancreatic serous cystic tumors, for example, many authors have reported
that several cases of serous oligocystic adenoma have been misdiagnosed as
mucinous cystadenoma and inappropriately managed
[6-16].

View larger version (10K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1A Schematic diagrams of shapes of cystic lesions.
"Multicystic shape" was defined as conglomeration of two or more
round cysts. We defined a cyst as a simple closed curve without concavity to
differentiate it from an internal locule in septate shape.
|
|

View larger version (14K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1B Schematic diagrams of shapes of cystic lesions.
"Lobulated shape with septation" was defined as a septate simple
closed curve that cannot be described as borders of the same circle.
"Internal locule" was defined as an angular closed curve without
protrusion from border of a primary lesion.
|
|

View larger version (9K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1C Schematic diagrams of shapes of cystic lesions.
"Lobulated shape without septation" was defined as a nonseptate
simple closed curve that cannot be described as borders of the same
circle.
|
|

View larger version (20K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1F Schematic diagrams of shapes of cystic lesions.
"Pleomorphic cystic shape" was defined as composed of three or
more cysts that include more than one oval or tubular cyst. We defined a
"tubular" or "oval" cyst as one having a conic
section, the plane of which was not parallel to axis, base, or generatrix of
the intersected cone.
|
|
Because each pancreatic cystic neoplasm has different malignant potential,
it is clinically valuable to determine characteristic imaging findings that
can enable the differentiation of serous oligocystic adenoma from other
macrocystic neoplasms. Mucinous cystadenomas span the spectrum of malignant
potential, with serous cystadenomas representing the most benign cystadenomas.
Intraductal papillary mucinous tumors of the pancreas mimic mucinous
cystadenomas and have similar biologic behavior
[11,
12,
17,
18]. Thus, the purpose of this
study was to describe the typical CT findings of serous oligocystic adenoma of
the pancreas and to identify features differentiating this disease from other
similarly presenting macrocystic neoplasms such as mucinous cystadenoma and
intraductal papillary mucinous tumor.
Materials and Methods
Data Collection
We searched the pathology database of our hospital for cases of serous
oligocystic adenoma, mucinous cystadenoma, and intraductal papillary mucinous
tumor of the pancreas during the period January 1996 to June 2003. Terms
searched for were "serous oligocystic adenoma and pancreas,"
"macrocystic serous adenoma and pancreas," "serous
cystadenoma and pancreas," "mucinous cystadenoma and
pancreas," and "branch duct type intraductal papillary mucinous
tumor and pancreas." All lesions were confirmed at histopathology of
samples obtained by pancreatic surgery or biopsy.
Sixty patients were identified as having one of these three pancreatic
macrocystic neoplasms. Seventeen were excluded because of the nonavailability
of appropriate CT images. Thus, 43 patients were selected for pathologic
review. An experienced pathologist reconfirmed the diagnoses by microscopic
review of pathology slides. However, as a result of the pathologic review, two
patients were excluded because their tumors were microcystic serous
cystadenomas, even if they were included initially because their initial
pathologic diagnosis was serous cystadenoma. Therefore, 41 patients were
finally enrolled. These comprised 13 men and 28 women (mean age, 54 years; age
range, 32-77 years). The final diagnoses were serous oligocystic adenoma in 10
patients (age range, 34-70 years; mean age, 48 years; 2 men, 8 women),
mucinous cystadenoma in 13 (age range, 32-77 years; mean age, 49 years; all
women), and intraductal papillary mucinous tumor in 18 (age range, 49-74
years; mean age, 60 years; 11 men, 7 women).

View larger version (140K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2 Serous oligocystic adenoma of pancreas in 49-year-old man.
Contrast-enhanced CT scan obtained during portal venous phase shows
multicystic shaped cystic mass (arrow) in neck of pancreas. Proximal
main pancreatic duct dilatation was also noted.
|
|
CT Acquisition
CT examinations of the 41 patients were performed using a Somatom Plus-4
scanner (Siemens Medical Solutions), a HighSpeed Advantage scanner (GE
Healthcare), or an MX8000 4-MDCT scanner (Philips Medical Systems) at our
institution. After unenhanced CT was performed, each patient received 120 mL
of a nonionic contrast material ([iopromide] Ultravist 370, Schering) through
an 18-gauge angiographic catheter inserted into a forearm vein. CT images were
routinely obtained during full inspiration with the patient in a supine
position. Contrast material was injected at 3 mL/s using an automatic power
injector.
Helical CT was performed using a single-detector scanner and the following
parameters: 5-mm collimation, 1:1 table pitch, and 5-mm reconstruction
intervals. If an MDCT scanner was used, the parameters were 2.5-mm detector
collimation, 20 mm/s table speed, 3.2-mm slice thickness, and 1.6-mm
reconstruction interval. Unenhanced CT was performed using the same
parameters. Multiphasic helical CT scans were obtained at 30 seconds (arterial
phase), at 40 seconds (pancreatic phase), and at 70 seconds (portal venous
phase) after the initiation of the contrast injection.
CT Imaging Analysis
Two experienced abdominal radiologists who were blinded to the specific
diagnoses and clinical information reviewed the CT images by consensus in
terms of the following morphologic features of the lesions: location (head,
neck, body, or tail), greatest dimension (measured in centimeters), presence
of mural nodules (present or absent), presence of wall calcification (present
or absent), extent of main pancreatic duct (MPD) dilatation (none, diffuse,
distal to, or proximal from the tumor), degree of MPD dilatation (normal,
mild, moderate, or severe), and tumor shape. All CT scans were reviewed on a
PACS workstation.
The presence of wall calcification was determined using unenhanced images.
The greatest diameter of the tumor and the extent of MPD dilatation were
measured with images obtained during the portal venous phase by one of the
reviewers. The degree of MPD dilatation was considered mild if the diameter
was more than 2 mm, moderate if more than 4 mm, and severe if more than 6 mm.
CT images of axially reconstructed sectional planes were reviewed.
Categorization of Shape
To identify morphologic features that can be used to differentiate these
tumors, tumor shape was categorized as multicystic, lobulated contour with or
without internal septation, smooth contour with or without internal septation,
pleomorphic cystic, and clubbed fingerlike cystic. A "multicystic
shape" was defined as a conglomeration of two or more round evenly sized
cysts (Fig. 1A). A
"lobulated shape" was defined as the shape of a simple closed
curve that could not be described as the borders of the same circle (Figs.
1B and
1C). A "smooth
shape" was a simple closed curve with the borders of the same circle
(Figs. 1D and
1E).
In order to differentiate the multicystic and multilobulated shapes with
internal septation, a "pleomorphic cystic shape" was defined as
one containing three or more cysts that should include more than one oval or
tubular cyst [1]
(Fig. 1F). A tubular or
oval-shaped cyst was defined as having a conic section with a plane that was
not parallel to the axis, base, or generatrix of the intersected cone
differentiating it from a round cyst. Finally, a "clubbed fingerlike
cystic shape" was defined as one having one or two tubular or oval cysts
(Fig. 1G).
Because we needed to differentiate the lobulated type with septation from
the multicystic, pleomorphic cystic, and clubbed fingerlike cystic shapes, we
defined an internal locule, seen in the lobulated and smooth shapes with
septation, as an angular closed curve without protrusion from the border of a
main lesion, whereas we defined a cyst as a simple closed curve without
concavity.
Statistical Analysis
The mean longest diameters of each type of lesion were compared using the
Mann-Whitney U test. Fisher's exact test was used to compare other
morphologic features. A p value of less than 0.05 was considered to
indicate a statistically significant difference. Because we wanted to identify
features capable of differentiating serous oligocystic adenoma of the pancreas
from other cystic tumors of the pancreas, statistical analysis was not
performed for comparisons between mucinous cystadenoma and intraductal
papillary mucinous tumor.
Results
Serous oligocystic adenomas ranged in longest diameter from 2.0 to 7.5 cm
(average, 4.0 ± 1.65 cm). In 8 (80%) of 10 patients, lesions were
located in the body or the tail of the pancreas. No lesion had mural nodules
or wall calcification. In terms of the extent and the degree of MPD
dilatation, 8 serous oligocystic adenomas (80%) were not accompanied by MPD
dilatation. Of the 7 shape categories, 6 serous oligocystic adenomas (60%) had
a lobulated shape (septate, 4; nonseptate, 2) and 3 serous oligocystic
adenomas (30%) had a multicystic shape (Figs.
2,
3A, and
3B; Tables
1 and
2).

View larger version (130K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3A Serous oligocystic adenoma of pancreas in 34-year-old woman.
Contrast-enhanced CT scans obtained during portal venous phase show lobulated
cystic mass in head of pancreas (white arrow, B). Mass has
many internal locules and subtle enhancing septa (black arrow,
B). Proximal main pancreatic duct dilatation (arrowhead,
A) is also noted.
|
|

View larger version (125K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3B Serous oligocystic adenoma of pancreas in 34-year-old woman.
Contrast-enhanced CT scans obtained during portal venous phase show lobulated
cystic mass in head of pancreas (white arrow, B). Mass has
many internal locules and subtle enhancing septa (black arrow,
B). Proximal main pancreatic duct dilatation (arrowhead,
A) is also noted.
|
|
Mucinous cystadenomas ranged from 2.0 to 12.5 cm (average, 6.07 ±
3.27 cm). Eleven (84.6%) of the 13 cysts were located in the tail of the
pancreas. Twelve patients (92.3%) had no mural nodules, and 4 (30.8%) had wall
calcification. Three patients (23.1%) showed MPD dilatation (2, mild proximal
dilatation; 1, diffuse moderate dilatation). In terms of shape, 12 cysts
(92.3%) had a smooth shape (septate, 7; nonseptate, 5)
(Fig. 4; Tables
1 and
2).

View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4 Mucinous cystadenoma of pancreas in 46-year-old woman.
Contrast-enhanced CT scan obtained during pancreatic phase shows smooth cyst
mass in tail of pancreas (white arrow). Mass has many internal
locules with septa (black arrow).
|
|
When serous oligocystic adenoma was compared with mucinous cystadenoma,
serous oligocystic adenoma showed a statistically significant difference in
lesion shape (p = 0.001). Serous oligocystic adenoma tended to have
the multicystic or the lobulated shape (Figs.
2,
3A, and
3B). On the other hand,
mucinous cystadenoma tended to have a smooth shape
(Table 1). Tumor location
(p = 0.108), greatest dimension (p =0.111), presence of
mural nodules (p = 1.0), presence of wall calcification (p =
0.104), and extent (p = 1.0) and degree (p = 0.476) of MPD
dilatation were statistically inadequate for differentiating serous
oligocystic adenoma from mucinous cystadenoma
(Table 2).
Intraductal papillary mucinous tumors ranged from 1.0 to 5.1 cm (average,
3.09 ± 1.25 cm). In 12 (66.7%) of 18 patients, cystic lesions were
located in the body or the tail of the pancreas, and in 5 patients (27.8%)
lesions were located in the head of the pancreas. Only one intraductal
papillary mucinous tumor (5.6%) had mural nodules, and only 3 (16.7%) had wall
calcification. Six patients (33.3%) had diffuse MPD dilatation. In terms of
shape, 10 lesions (55.6%) showed the pleomorphic cystic shape. Four lesions
(22.2%) had the clubbed fingerlike cystic shape (Figs.
5A,
5B,
5C,
6A, and
6B; Tables
1 and
2).

View larger version (145K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5A Branch duct type intraductal papillary mucinous tumor of
pancreas in 65-year-old man. Contrast-enhanced CT scans obtained during
pancreatic (A) and portal venous (B) phases show grapelike
cystic mass in head of pancreas (arrow, A). Mass contains
variable cysts such as oval and tubular cysts (arrows, B) and
is of typical pleomorphic cystic shape.
|
|

View larger version (145K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5B Branch duct type intraductal papillary mucinous tumor of
pancreas in 65-year-old man. Contrast-enhanced CT scans obtained during
pancreatic (A) and portal venous (B) phases show grapelike
cystic mass in head of pancreas (arrow, A). Mass contains
variable cysts such as oval and tubular cysts (arrows, B) and
is of typical pleomorphic cystic shape.
|
|

View larger version (104K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5C Branch duct type intraductal papillary mucinous tumor of
pancreas in 65-year-old man. Maximum-intensity-projection image reconstructed
in coronal plane shows variable cysts (arrow) and whole main
pancreatic duct dilatation (arrowhead).
|
|

View larger version (130K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6A Branch duct type intraductal papillary mucinous tumor of
pancreas in 64-year-old man. Contrast-enhanced CT scans obtained during
pancreatic phase show clubbed fingerlike cystic mass in tail of pancreas
(arrow, A). Dilatation of entire main pancreatic duct
(arrowhead, B) was also noted.
|
|

View larger version (131K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 6B Branch duct type intraductal papillary mucinous tumor of
pancreas in 64-year-old man. Contrast-enhanced CT scans obtained during
pancreatic phase show clubbed fingerlike cystic mass in tail of pancreas
(arrow, A). Dilatation of entire main pancreatic duct
(arrowhead, B) was also noted.
|
|
When we compared serous oligocystic adenomas with intraductal papillary
mucinous tumors, statistically significant differences were observed in the
shape and the extent of MPD dilatation
(Table 3). Serous oligocystic
adenomas tended to present the multicystic or the lobulated shape. On the
other hand, intraductal papillary mucinous tumors tended to have the
pleomorphic cystic or the clubbed fingerlike cystic shape (p = 0.001)
(Table 1). The majority of
serous oligocystic adenomas and intraductal papillary mucinous tumors showed
no MPD dilatations. However, when dilatation was observed, intraductal
papillary mucinous tumors showed diffuse or distal MPD dilatation (diffuse,
6/18; distal, 2/18; none, 10/18), whereas serous oligocystic adenomas showed
proximal MPD dilatation (2/10) (p = 0.025). Tumor location
(p = 0.751), greatest dimension (p = 0.194), presence of
mural nodules (p = 1.0), presence of wall calcification (p =
0.533), and degree of MPD dilatation (p = 0.525) were statistically
inadequate for differentiating serous oligocystic adenoma from intraductal
papillary mucinous tumor (Table
2).
Discussion
The potential malignant degeneration of the serous oligocystic adenoma is
low. Therefore, some authors advise that patients who are not clinically
suited for surgical treatment can be closely followed
[1,
2,
19]. However, serous
oligocystic adenomas can be easily misdiagnosed as another macrocystic
neoplasm, such as mucinous cystadenoma or intraductal papillary mucinous tumor
on preoperative imaging studies, and treated with surgical resection. Indeed,
specific CT features of serous oligocystic adenoma that helpfully
differentiate it from other cystic tumors of the pancreas are not well
described in the literature.
Several authors have attempted to identify radiologic findings capable of
differentiating serous oligocystic adenoma from other macrocystic neoplasms of
the pancreas and have reported the limited value of CT for this purpose
[1,
2,
6-8,
10-13,
15,
16]. However, those previous
reports were limited because detailed CT findings such as tumor shape or
accompanying MPD dilatation were not considered during image analysis. More
recently, Cohen-Scali et al.
[14] found that CT was helpful
for differentiating serous oligocystic adenoma and mucinous cystadenoma, and
they described specific CT findings indicating serous oligocystic
adenomanamely, location in the pancreatic head, a lobulated contour,
and the absence of wall enhancement. However, those authors did not include
intraductal papillary mucinous tumors in their study population. On the basis
of our clinical experiences, serous oligocystic adenoma is sometimes
misdiagnosed as intraductal papillary mucinous tumor, especially as the branch
duct type. Thus, we included intraductal papillary mucinous tumor as a
subgroup.
In this study, we found that lesion shape was the most useful feature among
the seven imaging features for the differential diagnosis of the three types
of cystic neoplasms of the pancreas. The multicystic and lobulated shapes were
prevalent in serous oligocystic adenomas, the smooth shape in mucinous
cystadenomas, and the pleomorphic cystic and the clubbed fingerlike cystic
shapes in branch duct type intraductal papillary mucinous tumors. This result
is in accord with the findings of Santos et al.
[20] regarding serous
oligocystic adenoma, in which serous oligocystic adenomas were most commonly
found to be composed of a few cysts and to contain tiny cysts that were
irregularly arranged and separated by mostly broad septa. The key morphologic
feature of intraductal papillary mucinous tumor can be considered to be a
presentation of branch pancreatic duct dilatation. In our study, dilated
branch pancreatic ducts appeared as clusters of small cysts with a grapelike
appearance, or as a multilocular cyst with papillary projections, or as a
single cystic lesion with lobulated or irregular margins communicating with a
dilated or normal MPD. This result is in accordance with the findings of
previous studies [17,
18].
Of the seven imaging features, the extent of MPD dilatation was also an
important morphologic feature that allowed differential diagnosis between
serous oligocystic adenoma and branch duct type intraductal papillary mucinous
tumor. If combined with dilated MPD, diffuse or distal MPD dilatation was
exclusively observed in intraductal papillary mucinous tumor, whereas proximal
MPD dilatation tended to be observed in serous oligocystic adenoma. Diffuse
MPD dilatation in intraductal papillary mucinous tumor was mostly associated
with mucin secreted from the tumor, whereas proximal MPD dilatation in serous
oligocystic adenoma is probably a mass effect due to extrinsic compression
[18,
21].
In previous reports [7,
13], wall calcification was
considered to be more frequent in serous cystic tumors than in mucinous
cystadenomas. However, in our study, no case of serous oligocystic adenoma
showed wall calcification. On the other hand, mucinous cystadenoma and
intraductal papillary mucinous tumor had some calcified walls. Thus, wall
calcification was not found to be a useful feature for the differentiation of
the three diseases. In addition, several previous studies
[14,
16,
19] reported that lesion
location and patient sex and age may be distinguishing features for these
three disease entities at diagnosis. In our study, these features did not show
statistical significance. However, because our study population was small,
these findings must be confirmed by a large series.
Our study has several limitations. First, this was a retrospective study
and was subject to all biases affecting such studies, including that
radiologic-pathologic correlation was not possible. Second, different CT
scanners were used, and therefore CT parameters are not the same in each
patient (5-mm detector collimation in single-detector CT vs 2.5 mm in MDCT).
Last, the number of patients who were enrolled in this study was small.
Because MDCT provides improved spatial resolution that allows good-quality
multiplanar reformation compared with single-detector CT, further study in
large population using MDCT will be warranted.
In conclusion, serous oligocystic adenoma of the pancreas has typical CT
findings that differ from other macrocystic neoplasms such as mucinous
cystadenoma and intraductal papillary mucinous tumor. The typical imaging
features of serous oligocystic adenoma are either a multicystic or a lobulated
cystic lesion with or without internal septation (specificity, 90%). The
typical imaging features of mucinous cystadenoma are a smooth cystic lesion
with or without internal septation, and those of intraductal papillary
mucinous tumor are either a pleomorphic cystic or clubbed, fingerlike cystic
lesion. In terms of MPD dilatation, if MPD dilatation is detected, serous
oligocystic adenoma has proximal MPD dilatation on CT.
References
- Egawa N, Maillet B, Schroder S, Mukai K, Kloppel G. Serous
oligocystic and ill-demarcated adenoma of the pancreas. Virchows
Arch 1994; 424:13
-17[Medline]
- Inoue S, Yamaguchi K, Shimizu S, et al. Serous cystadenoma of the
pancreas with atypical imaging features: a new variant of serous cystadenoma
of the pancreas? Pancreas 1998;16
: 102-106[Medline]
- Le Borgne J, de Calan L, Partensky C. Cystadenomas and
cystadenocarcinomas of the pancreas: a multi-institutional retrospective study
of 398 cases. French Surgical Association. Ann Surg1999; 230:152
-161[CrossRef][Medline]
- Bassi C, Salvia R, Molinari E. Biasutti C, Falconi M, Pederzoli P.
Management of 100 consecutive cases of pancreatic serous cystadenoma: wait for
symptoms and see at imaging or vice versa? World J
Surg 2003; 27:319
-323[CrossRef][Medline]
- Procacci C, Carbognin G, Biasiutti C, et al. Serous cystadenoma of
the pancreas: imaging findings. Radiol Med (Torino)2001; 102:23
-31
- Kruslin B, Zovak M, Doko M, Belicza M. Serous oligocystic and
ill-demarcated adenoma of the pancreas. Virchows Arch2002; 440:441
-442[CrossRef][Medline]
- Warshaw AL, Compton CC, Lewandrowski K, Cardenosa G, Mueller PR.
Cystic tumors of the pancreas: new clinical, radiologic, and pathologic
observations in 67 patients. Ann Surg1990; 212:432
-443[Medline]
- Ooi LL, Ho GH, Chew SP, Low CH, Soo KC. Cystic tumours of the
pancreas: a diagnostic dilemma. Aust N Z J Surg1998; 68:844
-846[CrossRef][Medline]
- Capella C, Solcia E, Kloppel G, Hruban RH. Serous cystic neoplasms
of the pancreas. In: Hamilton SR, Aaltonen LA, eds. Pathology and
genetics of tumor of the digestive system: WHO classification of
tumors. Lyon, France: IARC Press, 2000:231
-233
- Lewandrowski K, Warshaw A, Compton C. Macrocystic serous
cystadenoma of the pancreas: a morphologic variant differing from microcystic
adenoma. Hum Pathol 1992;23
: 871-875[CrossRef][Medline]
- Compagno J, Oertel JE. Microcystic adenomas of the pancreas
(glycogen-rich cystadenomas): a clinicopathologic study of 34 cases.
Am J Clin Pathol 1978;69
: 289-298[Medline]
- Warshaw AL, Compton CC, Lewandrowski K, Cardenosa G, Mueller PR.
Cystic tumors of the pancreas: new clinical, radiologic, and pathologic
observations in 67 patients. Ann Surg1990; 212:432
-443[Medline]
- Procacci C, Graziani R, Bicego E, et al. Serous cystadenoma of the
pancreas: report of 30 cases with emphasis on the imaging findings.
J Comput Assist Tomogr 1997;21
: 373-382[CrossRef][Medline]
- Cohen-Scali F, Vilgrain V, Brancatelli G, et al. Discrimination of
unilocular macrocystic serous cystadenoma from pancreatic pseudocyst and
mucinous cystadenoma with CT: initial observations.
Radiology 2003;228
: 727-733[Abstract/Free Full Text]
- Curry CA, Eng J, Horton KM, et al. CT of primary cystic pancreatic
neoplasms: can CT be used for patient triage and treatment?
AJR 2000; 175:99
-103[Abstract/Free Full Text]
- Chatelain D, Hammel P, O'Toole D, et al. Macrocystic form of serous
pancreatic cystadenoma. Am J Gastroenterol2002; 97:2566
-2571[CrossRef][Medline]
- Taouli B, Vilgrain V, O'Toole D, Vullierme MP, Terris B, Menu Y.
Intraductal papillary mucinous tumors of the pancreas: features with
multimodality imaging. J Comput Assist Tomogr2002; 26:223
-231[CrossRef][Medline]
- Hong TM, Lee RC, Chiang JH, Chang CY. Intraductal papillary
mucinous tumor of the pancreas: computerized tomography and magnetic resonance
imaging features. Kaohsiung J Med Sci2003; 19:55
-61[Medline]
- Khurana B, Mortele KJ, Glickman J, Silverman SG, Ros PR.
Macrocystic serous adenoma of the pancreas: radiologic-pathologic correlation.
AJR 2003; 181:119
-123[Abstract/Free Full Text]
- Santos LD, Chow C, Henderson CJ, et al. Serous oligocystic adenoma
of the pancreas: a clinicopathologic and immunohistochemical study of three
cases with ultrastructural findings. Pathology2002; 34:148
-156[CrossRef][Medline]
- Maguchi H, Takahashi K, Katanuma A, Hayashi T, Yoshida A, Sakurai
Y. Intraductal papillary mucinous tumor: imaging diagnosis [in Japanese].
Nippon Geka Gakkai Zasshi 2003;104
: 447-452[Medline]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. E. Lee, Y. Kwon, J.-Y. Jang, Y.-H. Kim, D. W. Hwang, M. A. Kim, S. H. Kim, and S.-W. Kim
The Morphological Classification of a Serous Cystic Tumor (SCT) of the Pancreas and Evaluation of the Preoperative Diagnostic Accuracy of Computed Tomography
Ann. Surg. Oncol.,
August 1, 2008;
15(8):
2089 - 2095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Kim, D. H. Lee, Y. T. Ko, J. W. Lim, H. C. Kim, and K. W. Kim
CT of Serous Cystadenoma of the Pancreas and Mimicking Masses
Am. J. Roentgenol.,
February 1, 2008;
190(2):
406 - 412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Katz, D. M. Friedel, D. Kho, N. Georgiou, and J. J. Hines
Relative Accuracy of CT and MRI for Characterization of Cystic Pancreatic Masses
Am. J. Roentgenol.,
September 1, 2007;
189(3):
657 - 661.
[Full Text]
[PDF]
|
 |
|